1. Xu, Nan, Ren, Yunpeng, Bao, Yufang, Xie, Gangcai, Wang, Yongbo. 2023. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C. In Cell reports, 42, 113041. doi:10.1016/j.celrep.2023.113041. https://pubmed.ncbi.nlm.nih.gov/37682709/
2. Liu, Kai, Zheng, Minying, Lu, Rui, Li, Yuwei, Zhang, Shiwu. 2020. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. In Cancer cell international, 20, 213. doi:10.1186/s12935-020-01304-w. https://pubmed.ncbi.nlm.nih.gov/32518522/
3. Zhou, Chaoting, Wang, Luyang, Hu, Wanye, Li, Yanchun, Wang, Ying. . CDC25C is a prognostic biomarker and correlated with mitochondrial homeostasis in pancreatic adenocarcinoma. In Bioengineered, 13, 13089-13107. doi:10.1080/21655979.2022.2078940. https://pubmed.ncbi.nlm.nih.gov/35615982/
4. Stern, Esther, Pines, Guy, Lazar, Li Or, Peled, Amnon, Wald, Ori. 2023. CDC25C Protein Expression Correlates with Tumor Differentiation and Clinical Outcomes in Lung Adenocarcinoma. In Biomedicines, 11, . doi:10.3390/biomedicines11020362. https://pubmed.ncbi.nlm.nih.gov/36830899/
5. Galusic, Davor, Lucijanic, Marko, Livun, Ana, Drmic Hofman, Irena, Kusec, Rajko. 2020. CDC25c expression in patients with myelofibrosis is associated with stronger myeloproliferation and shorter overall survival. In Wiener klinische Wochenschrift, 134, 83-85. doi:10.1007/s00508-020-01738-2. https://pubmed.ncbi.nlm.nih.gov/32945945/
6. St Clair, Selvon, Manfredi, James J. 2006. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53. In Cell cycle (Georgetown, Tex.), 5, 709-13. doi:. https://pubmed.ncbi.nlm.nih.gov/16582636/